References: Kishan AU, Sun Y, Tree AC, et al. Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium ...

Surufatinib did not provide an overall survival (OS) benefit over placebo in patients with advanced neuroendocrine tumors (NETs) enrolled in a pair of phase 3 trials. However, there was a high ...

The cohorts had similar proportions of females (39% and 40%), non-White (6% vs 4%) and Hispanic (4% vs 1%) patients, those with newly-diagnosed disease (42% for both), and months post MM diagnosis ...

Among the included patients, 1359 (43.8%) had uncontrolled pain, and 1044 (33.6%) experienced high-impact pain. Patients with uncontrolled pain were nearly 10 times more likely to develop OUD ...

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

Researchers evaluated an electronic health record-based intervention that identified patients with metastatic cancer for a multipronged approach to their in-hospital care.

HealthDay News — Rates of colorectal cancer detection through colonoscopy screening are similar for adults aged 45 to 49 years and 50 to 54 years, according to a research letter published online ...

A prognostic index can be used to identify patients with estrogen receptor (ER)-positive, HER2-negative early breast cancer who can safely forgo adjuvant chemotherapy as well as patients who require ...

Combination treatment with zanubrutinib and venetoclax has elicited durable responses in patients with treatment-naïve chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and ...